Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Else Nutrition continues incredible November with Danone deal

 Trevor Abes Trevor Abes , The Market Online
0 Comments| November 13, 2023

{{labelSign}}  Favorites
{{errorMessage}}

  • Else Nutrition (TSX:BABY) has signed a multi-staged collaboration agreement with Danone (OTCQX:GPDNF), a global leader in fresh dairy products, plant-based products, water and specialized nutrition
  • Pending a definitive agreement, Danone will manufacture, market and commercialize Else’s products
  • Else Nutrition is an award-winning global food and nutrition company offering plant-based products for infants, toddlers, children and adults
  • Else Nutrition stock (TSX:BABY) is up by 63.08 per cent trading at C$0.53 per share as of 10:50 am ET. The stock has been on a tear in November adding 194.4 per cent month to date

Else Nutrition (TSX:BABY) has signed a multi-staged collaboration agreement with Danone (OTCQX:GPDNF), a global leader in fresh dairy products, plant-based products, water and specialized nutrition.

Danone generated sales of €27.661 billion in 2022 backed by a portfolio of household brands including Activia, evian, Volvic and Danonino.

The companies have agreed to a letter of intent detailing the collaboration, with certain commercial terms still to be finalized.

The first stage of the collaboration will see the global consumer staples company enter into a license agreement to manufacture, market and commercialize Else’s products, which will be integrated into Danone’s specialized nutrition portfolio.

Negotiations for other opportunities beyond product commercialization will follow, with a definitive agreement estimated by the end of Q1 2024.

The collaboration continues Else’s trend of rapidly rising exposure over the past few years, including its expansion into the U.K., availability in over 10,000 locations across all 50 U.S. states, and a strategic presence in the Chinese market.

Else Nutrition is an award-winning global food and nutrition company offering plant-based products for infants, toddlers, children and adults. It specializes in non-soy and non-dairy alternatives. Potential investors can learn more about Else by watching our feature on the company as part of The Market Herald’s Leading Edge.

Else Nutrition stock (TSX:BABY) is up by 63.08 per cent trading at C$0.53 per share as of 10:50 am ET. The stock has been on a tear in November adding 194.4 per cent month to date.

Join the discussion: Find out what everybody’s saying about this Canadian microcap stock on the Else Nutrition Holdings Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company